A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the ...
Researchers in the US placed electrodes in the brain of a patient on the drug to study its impact on the region that is associated with pleasure, motivation and reward.
Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...
For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...
The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...
Patients with T2D and inflammatory arthritis who received GLP-1 RAs vs SGLT2 inhibitors had lower rates of hypoglycemia, serious infections, and AKI.
Robbie Williams warns GLP-1 drugs may cause vision loss. What does this mean for food & beverage innovation and natural ...
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...
Nearly 1 in 5 people with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis were prescribed a GLP-1 ...
As the prevalence of obesity in the United States rises, drugs like Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results